These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 8815952

  • 1. Effects of ceruletide on perioral movements and the dopamine receptor-adenylate cyclase system in rats chronically treated with fluphenazine.
    Ashizawa T, Saito T, Takahata N.
    Psychopharmacology (Berl); 1996 Jun; 125(3):185-94. PubMed ID: 8815952
    [Abstract] [Full Text] [Related]

  • 2. Effects of ceruletide on the dopamine receptor-adenylate cyclase system in striatum and frontal cortex of rats chronically treated with haloperidol.
    Hatta Y, Hatta S, Saito T.
    Psychopharmacology (Berl); 1993 Jun; 110(4):383-9. PubMed ID: 7870906
    [Abstract] [Full Text] [Related]

  • 3. Effect of chronic ceruletide treatment on dopaminergic neurotransmitters, receptors and their mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile.
    Hirata H, Ogawa N, Asanuma M, Ota Z, Mori A.
    Brain Res; 1993 Feb 26; 604(1-2):197-204. PubMed ID: 8457848
    [Abstract] [Full Text] [Related]

  • 4. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep 26; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

  • 5. Chronic desipramine treatment influences D1 stimulation and D2 inhibition (dual control) of adenylate cyclase by dopamine in rat striatum.
    Okada F, Horikawa T, Tokumitsu Y, Nomura Y.
    Neurochem Int; 1994 Jan 26; 24(1):23-7. PubMed ID: 8130732
    [Abstract] [Full Text] [Related]

  • 6. Modulation by GTP of basal and agonist-stimulated striatal adenylate cyclase activity following chronic blockade of D1 and D2 dopamine receptors: involvement of G proteins in the development of receptor supersensitivity.
    Schettini G, Ventra C, Florio T, Grimaldi M, Meucci O, Marino A.
    J Neurochem; 1992 Nov 26; 59(5):1667-74. PubMed ID: 1402912
    [Abstract] [Full Text] [Related]

  • 7. Altered dopamine receptor mediated signal transmission in the striatum of aged rats.
    May T, Sugawa M.
    Brain Res; 1993 Feb 26; 604(1-2):106-11. PubMed ID: 8457839
    [Abstract] [Full Text] [Related]

  • 8. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631
    [Abstract] [Full Text] [Related]

  • 9. Acute effects of D1- and D2-receptor agonist and antagonist drugs on somatostatin binding, inhibition of adenylyl cyclase activity and accumulation of inositol 1,4,5-trisphosphate in the rat striatum.
    Izquierdo-Claros RM, Boyano-Adánez MC, Larsson C, Gustavsson L, Arilla E.
    Brain Res Mol Brain Res; 1997 Jul 07; 47(1-2):99-107. PubMed ID: 9221906
    [Abstract] [Full Text] [Related]

  • 10. Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways.
    Undie AS, Berki AC, Beardsley K.
    Neuropharmacology; 2000 Jul 07; 39(1):75-87. PubMed ID: 10665821
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antagonistic effects of isofloxythepin on dopamine D1 and D2 receptors and behaviors in rats.
    Lau YS, Fung YK, Anderson TM.
    Gen Pharmacol; 1997 Nov 07; 29(5):729-36. PubMed ID: 9347318
    [Abstract] [Full Text] [Related]

  • 13. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 07; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 14. Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity.
    Cameron DL, Crocker AD.
    Neurosci Lett; 1988 Jul 19; 90(1-2):165-71. PubMed ID: 3045699
    [Abstract] [Full Text] [Related]

  • 15. Dopamine-opioid interactions in the rat striatum: a modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction.
    Unterwald EM, Cuntapay M.
    Neuropharmacology; 2000 Jan 28; 39(3):372-81. PubMed ID: 10698003
    [Abstract] [Full Text] [Related]

  • 16. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
    Andersen PH, Braestrup C.
    J Neurochem; 1986 Dec 28; 47(6):1822-31. PubMed ID: 2945903
    [Abstract] [Full Text] [Related]

  • 17. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ, Battaglia G, Norman AB, Creese I.
    Mol Pharmacol; 1987 Jan 28; 31(1):50-7. PubMed ID: 3100940
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dopamine enhances somatostatin receptor-mediated inhibition of adenylate cyclase in rat striatum and hippocampus.
    Rodríguez-Sánchez MN, Puebla L, López-Sañudo S, Rodríguez-Martín E, Martín-Espinosa A, Rodríguez-Pena MS, Juarranz MG, Arilla E.
    J Neurosci Res; 1997 May 01; 48(3):238-48. PubMed ID: 9160246
    [Abstract] [Full Text] [Related]

  • 20. Dopamine D1 and D2 receptors and their signal system present in coated vesicles prepared from bovine striatal tissue.
    Ozaki N, Moroi K, Kadota T, Suzuki S, Kadota K.
    J Neurochem; 1994 Feb 01; 62(2):582-91. PubMed ID: 8294921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.